National Center for Research Resources (NCRR): Communicable Diseases trials
The registry lists 25 Communicable Diseases studies with National Center for Research Resources (NCRR) as lead sponsor. 0 are open to participants now and 0 have results posted.
Phase 1 3Phase 2 10Phase 3 8No phase 8(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Phase III Randomized Study of Oral Acyclovir in Infants With Herpes Simplex Virus Infection Limited to Skin, Eyes, and MouthCompletedNCT00006135Phase 3
- Study of the Predictors of the Course and Early Outcome of Patients With Systemic Lupus Erythematosus: Nature Versus NurtureCompletedNCT00006134
- Randomized Study of Oral Contraceptives or Hormone Replacement Therapy in Women With Systemic Lupus ErythematosusCompletedNCT00006133Not applicable
- Phase III Randomized Study of Oral Acyclovir in Infants With Herpes Simplex Virus Infection Involving the Central Nervous SystemStatus unknownNCT00006132Phase 3
- Diagnostic Study of Adrenal Cortical Function in Children With Septic ShockCompletedNCT00005890Not applicable
- Study of the Relationship Between Feeding and Late Onset Sepsis and/or Necrotizing Enterocolitis in Low Birth Weight InfantsCompletedNCT00005888Not applicable
- Phase I/II Study of Itraconazole for Blastomycosis, Histoplasmosis, and SporotrichosisCompletedNCT00004811Phase 1/2
- Phase II Pilot Study of Fluconazole for Histoplasmosis, Blastomycosis, and SporotrichosisCompletedNCT00004808Phase 2
- Phase III Randomized Study of High Vs Standard Dose of Interferon Alfa for Chronic Hepatitis CCompletedNCT00004804Phase 3
- Phase II/III Randomized, Double-Blind, Placebo-Controlled Study of Dehydroepiandrosterone in Women With Mild to Moderate Systemic Lupus ErythematosusCompletedNCT00004795Phase 2/3
- Phase III Randomized, Placebo-Controlled Study of Acyclovir Oral Suspension for Neonatal Herpes Simplex Virus Infection Limited to the Skin, Eyes, and MouthCompletedNCT00004757Phase 3
- Study of Individualized Instruction Versus Pamphlet in Systemic Lupus ErythematosusCompletedNCT00004756Not applicable
- Phase II Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Mucoid Exopolysaccharide Pseudomonas Aeruginosa Immune Globulin for Cystic FibrosisCompletedNCT00004747Phase 2
- Phase II Study of Long-Term Dehydroepiandrosterone for Systemic Lupus ErythematosusCompletedNCT00004665Phase 2
- Randomized Placebo-Controlled Study of Aerobic Exercise and Resistance Training Plus Megestrol Acetate for HIV-WastingCompletedNCT00004664Not applicable
- Epidemiologic Study of Reproductive Outcome in Women With Systemic Lupus ErythematosusCompletedNCT00004663
- Phase III Randomized, Double-Blind, Placebo-Controlled Study of Dehydroepiandrosterone in Women With Active Systemic Lupus ErythematosusCompletedNCT00004662Phase 3
- Phase I/II Study of High-Dose Acyclovir for Central Nervous System or Disseminated Neonatal Herpes Simplex Virus InfectionCompletedNCT00004644Phase 1/2
- Phase II Pilot Study of Cytarabine for Refractory Systemic Lupus ErythematosusCompletedNCT00004643Phase 2
- Phase I/II Study of Human Anti-Cytomegalovirus (CMV) Monoclonal Antibody MSL-109 in Newborns With Symptomatic Congenital CMV Infection Without Central Nervous System DiseaseCompletedNCT00004642Phase 1/2
- Phase III Randomized Controlled Study of Morphine and Nortriptyline in the Management of Postherpetic NeuralgiaCompletedNCT00004390Phase 3
- Ultraviolet Light Therapy for Systemic Lupus ErythematosusStatus unknownNCT00004375Phase 2
- Multicenter Study of Nontuberculous Mycobacteria in Cystic Fibrosis PatientsCompletedNCT00004296
- Phase III Randomized, Controlled Study of Ganciclovir for Symptomatic Congenital Cytomegalovirus InfectionCompletedNCT00004278Phase 3
- Phase II Placebo Controlled Study of Thalidomide in Patients With Mycobacterial and HIV InfectionsCompletedNCT00004276Phase 2